Healthcare Sector Review: Winning and Losing Stocks on Oct 19th

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Intuitive Surgical, Inc. (NASDAQ:ISRG): The shares closed at $417.62, up $34.86, or 9.11%, on the day. Its market capitalization is $16.32 billion. About the company: Intuitive Surgical, Inc. design, manufactures and markets surgical systems. The Company’s surgical system controls Intuitive Surgical endoscopic instruments, including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories during surgical procedures.
  • Human Genome Sciences (NASDAQ:HGSI): The shares closed at $13.98, up $1.16, or 9.05%, on the day. Its market capitalization is $2.67 billion. About the company: Human Genome Sciences, Inc. researches and develops proprietary pharmaceutical and diagnostic products. The Company’s products predict, prevent, detect, treat, and cure disease based on the discovery of human and microbial genes.
  • Dynavax Tech. Corp. (NASDAQ:DVAX): The shares closed at $2.51, up $0.14, or 5.91%, on the day. Its market capitalization is $309.78 million. About the company: Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
  • St. Jude Medical, Inc. (NYSE:STJ): The shares closed at $38.95, up $1.61, or 4.31%, on the day. Its market capitalization is $12.83 billion. About the company: St. Jude Medical, Inc. develops, manufactures, and distributes medical devices for the worldwide cardiovascular market. The Company serves patients and its health care customers with products and services including heart valves, cardiac rhythm management systems, specialty catheters, and other cardiovascular devices.
  • Achillion Pharmaceuticals (NASDAQ:ACHN): The shares closed at $6.25, up $0.24, or 3.99%, on the day. Its market capitalization is $435.74 million. About the company: Achillion Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops solutions for infectious diseases such as HIV, hepatitis, and resistant bacterial infections.

Losers (% price change)

  • Gentiva Health Services (NASDAQ:GTIV): The shares closed at $3.60, down $0.54, or 13.04%, on the day. Its market capitalization is $110.19 million. About the company: Gentiva Health Services, Inc. provides specialty pharmaceutical and home health care services. The company provides products and services for hemophilia and bleeding disorders, growth hormone deficiency, RSV prevention and nutritional support services. Gentiva also provides services for diabetes, cardiovascular conditions, post-surgical care, orthopedic rehabilitation and other diseases.
  • Alphatec Holdings, Inc. (NASDAQ:ATEC): The shares closed at $2.04, down $0.19, or 8.52%, on the day. Its market capitalization is $182.02 million. About the company: Alphatec Holdings, Inc. manufactures medical devices. The Company produces products for the surgical treatment of spinal disorders. Alphatec manufactures spine screws, spinal spacers, and plates.
  • Metabolix, Inc. (NASDAQ:MBLX): The shares closed at $4.69, down $0.43, or 8.4%, on the day. Its market capitalization is $159.84 million. About the company: Metabolix, Inc. produces biobased, biodegradable, natural plastics and chemicals.
  • Skilled Healthcare Group (NYSE:SKH): The shares closed at $3.62, down $0.31, or 7.89%, on the day. Its market capitalization is $137.63 million. About the company: Skilled Healthcare Group Inc. operates nursing and assisted-living homes in California, Texas, Kansas, and Nevada.
  • Endologix, Inc. (NASDAQ:ELGX): The shares closed at $10.60, down $0.82, or 7.18%, on the day. Its market capitalization is $609.69 million. About the company: Endologix, Inc. develops, manufactures, sells, and markets minimally invasive treatments for vascular diseases. The Company’s products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms. Endologix’s products are sold in the United States as well as international markets.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>